Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it
Most of the evidences for beneficial effects of beta-blockers in patients with acute myocardial infarction (AMI) were from the clinical studies published in the pre-reperfusion era when anti-platelet drugs, statins or inhibitors of renin-angiotensin-aldosterone system which are known to reduce cardi...
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Korean Society of Critical Care Medicine
2023-08-01
|
| Sarja: | Acute and Critical Care |
| Aiheet: | |
| Linkit: | http://www.accjournal.org/upload/pdf/acc-2023-00955.pdf |